High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies

Journal of the American Society of Nephrology

Volumn 27, Issue 4, 2016, Pages 1245-1253

  Bu, Fengxiao ^a   Borsa, Nicolo Ghiringhelli ^a   Jones, Michael B ^a   Takanami, Erika ^a   Nishimura, Carla ^a   Hauer, Jill J ^b   Azaiez, Hela ^a   Black Ziegelbein, Elizabeth A ^a   Meyer, Nicole C ^a   Kolbe, Diana L ^a   Li, Yingyue ^a   Frees, Kathy ^a   Schnieders, Michael J ^b   Thomas, Christie ^a,c   Nester, Carla ^a,c   Smith, Richard J H ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b University of Iowa   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT FACTOR; COMPLEMENT FACTOR H; COMPLEMENT FACTOR HR5; COMPLEMENT FACTOR I; MEMBRANE COFACTOR PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; COMPLEMENT COMPONENT C3;

ADOLESCENT; ADULT; ARTICLE; BIOINFORMATICS; C3 GLOMERULOPATHY; CHILD; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; FEMALE; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; GLOMERULOPATHY; HETEROZYGOSITY; HIGH THROUGHPUT SCREENING; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; MOLECULAR MODEL; PATHOGENICITY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN FUNCTION; REGULATOR GENE; THROMBOTIC THROMBOCYTOPENIC PURPURA; VALIDATION PROCESS; YOUNG ADULT; GENETICS; GLOMERULUS; IMMUNOLOGY; KIDNEY DISEASES; PROCEDURES; THROMBOTIC MICROANGIOPATHIES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; FEMALE; GENETIC TESTING; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; THROMBOTIC MICROANGIOPATHIES;

EID: 85017040990     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015040385     Document Type: Article

References (32)

1. Biesecker LG, Green RC: Diagnostic clinical genome and exome sequencing. N Engl J Med 370: 2418–2425, 2014
2. Renkema KY, Stokman MF, Giles RH, Knoers NV: Next-generation sequencing for research and diagnostics in kidney disease. Nat Rev Nephrol 10: 433–444, 2014
3. Boyd SD: Diagnostic applications of high-throughput DNA sequencing. Annu Rev Pathol 8: 381–410, 2013
4. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J: Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 12: 745–755, 2011
5. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 369: 1502–1511, 2013
6. George JN, Nester CM: Syndromes of thrombotic microangiopathy. N Engl J Med 371: 654–666, 2014
7. Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A: Genetics of atypical hemolytic uremic syndrome (aHUS). Semin Thromb Hemost 40: 422–430, 2014
8. Kavanagh D, Goodship TH, Richards A: Atypical hemolytic uremic syndrome. Semin Nephrol 33: 508–530, 2013
9. Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS: The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease. J Biol Chem 290: 9500–9510, 2015
10. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413: 488–494, 2001
11. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL: Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 132: 794–799, 2000
12. Barbour, TD, Ruseva, MM, Pickering, MC: Update on C3 glomerulopathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2014.
13. Barbour TD, Pickering MC, Terence Cook H: Dense deposit disease and C3 glomerulopathy. Semin Nephrol 33: 493–507, 2013
14. Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ: Defining the complement biomarker profile of C3 glomerulopathy. Clin J Am Soc Nephrol 9: 1876–1882, 2014
15. Xiao X, Pickering MC, Smith RJ: C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. Semin Thromb Hemost 40: 465–471, 2014
16. Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ: Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25: 55–64, 2014
17. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S: Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLOS Comput Biol 6: e1001025, 2010
18. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A; NISC Comparative Sequencing Program: Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 15: 901–913, 2005
19. Schwarz JM, Cooper DN, Schuelke M, Seelow D: MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11: 361–362, 2014
20. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 7: 248–249, 2010
21. Kumar P, Henikoff S, Ng PC: Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073–1081, 2009
22. Chun S, Fay JC: Identification of deleterious mutations within three human genomes. Genome Res 19: 1553–1561, 2009
23. Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ: Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 115: 379–387, 2010
24. Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M; European Working Party on Complement Genetics in Renal Diseases: Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 24: 475–486, 2013
25. Shearer AE, Black-Ziegelbein EA, Hildebrand MS, Eppsteiner RW, Ravi H, Joshi S, Guiffre AC, Sloan CM, Happe S, Howard SD, Novak B, Deluca AP, Taylor KR, Scheetz TE, Braun TA, Casavant TL, Kimberling WJ, Leproust EM, Smith RJ: Advancing genetic testing for deafness with genomic technology. J Med Genet 50: 627–634, 2013
26. Zand L, Lorenz EC, Cosio FG, Fervenza FC, Nasr SH, Gandhi MJ, Smith RJ, Sethi S: Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J Am Soc Nephrol 25: 1110–1117, 2014
27. Reich HN, Troyanov S, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry: Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18: 3177–3183, 2007
28. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C; French Society of Pediatric Nephrology: Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18: 2392–2400, 2007
29. Bruneau S, Néel M, Roumenina LT, Frimat M, Laurent L, Frémeaux-Bacchi V, Fakhouri F: Loss of DGK« induces endothelial cell activation and death independently of complement activation. Blood 125: 1038–1046, 2015
30. Shi Y, Xia Z, Zhang J, Best R, Wu C, Ponder JW, Ren P: The Polarizable Atomic Multipole-based AMOEBA Force Field for Proteins. J Chem Theory Comput 9: 4046–4063, 2013
31. Ren P, Wu C, Ponder JW: Polarizable Atomic Multipole-based Molecular Mechanics for Organic Molecules. J Chem Theory Comput 7: 3143–3161, 2011
32. Shapovalov MV, Dunbrack RL Jr: A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Structure 19: 844–858, 2011